Lidocaine, known as an amide-type local anesthetic, has been indicated to promote DNA demethylation 8, 37 and increase the cytotoxicity of cisplatin in breast cancer cells via upregulation of RASSF1A demethylation 8. Here, RASSF1 is linked to breast cancer.